Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bryskier

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|September 19, 2000
In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4N Rastogi, K S Goh, M Berchel, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimineN Rastogi, K S Goh, A Bryskier, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosisN Rastogi, K S Goh, A Bryskier, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCGN Rastogi, K S Goh, M Berchel, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2000
In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensisJ M Rolain, M Maurin, A Bryskier, et al.
Chemotherapy|January 1, 1986
Study of the diffusion of cefmenoxime into the bronchial secretionsC Serieys, E Bergogne-Berezin, H Kafe, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophilsD Vazifeh, A Preira, A Bryskier, et al.
Annales De Biologie Clinique|January 1, 1981
[Role of Clostridium and its toxin in pseudo-membranous colitis (author's transl)]A Bryskier, J Doll, M T Labro, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmasC M Bebear, H Renaudin, A Bryskier, et al.
Pathologie-Biologie|May 1, 1983
[In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam]M O Husson, A Bryskier, D Izard, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|September 19, 2000
In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4N Rastogi, K S Goh, M Berchel, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimineN Rastogi, K S Goh, A Bryskier, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosisN Rastogi, K S Goh, A Bryskier, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCGN Rastogi, K S Goh, M Berchel, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2000
In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensisJ M Rolain, M Maurin, A Bryskier, et al.
Chemotherapy|January 1, 1986
Study of the diffusion of cefmenoxime into the bronchial secretionsC Serieys, E Bergogne-Berezin, H Kafe, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophilsD Vazifeh, A Preira, A Bryskier, et al.
Annales De Biologie Clinique|January 1, 1981
[Role of Clostridium and its toxin in pseudo-membranous colitis (author's transl)]A Bryskier, J Doll, M T Labro, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmasC M Bebear, H Renaudin, A Bryskier, et al.
Pathologie-Biologie|May 1, 1983
[In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam]M O Husson, A Bryskier, D Izard, et al.
Pageof 11